Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN expression

Journal of Cellular Biochemistry

Volumn 113, Issue 11, 2012, Pages 3528-3535

  Yang, Yanmei ^a   Zhang, Xinyu ^a   Jia, Shuzhao ^a   Yang, Shumeng ^a   Yang, Yue ^a   Yang, Tuoyun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

AKT; ARSENIC TRIOXIDE; cdc2; G2 M ARREST; PTEN

Indexed keywords

ARSENIC TRIOXIDE; CYCLIN DEPENDENT KINASE 1; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SERINE; SMALL INTERFERING RNA; THREONINE; TYROSINE; UNCLASSIFIED DRUG; WEE1 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER CELL CARCINOMA; M PHASE CELL CYCLE CHECKPOINT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; ARSENICALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN B; DOSE-RESPONSE RELATIONSHIP, DRUG; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NUCLEAR PROTEINS; OXIDES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84866502736     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24230     Document Type: Article

References (43)

1. Arafa el SA, Zhu Q, Shah ZI, Wani G, Barakat BM, Racoma I, El-Mahdy MA, Wani AA,. 2011. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Mutat Res 706: 28-35.
2. Baig RM, Mahjabeen I, Sabir M, Masood N, Hafeez S, Malik FA, Kayani MA,. 2011. Genetic changes in the PTEN gene and their association with breast cancer in Pakistan. Asian Pac J Cancer Prev 12: 2773-2778.
3. Berenson JR, Yeh HS,. 2006. Arsenic compounds in the treatment of multiple myeloma: a new role for a historical remedy. Clin Lymphoma Myeloma 7: 192-198.
4. Bruix J, Boix L, Sala M, Llovet JM,. 2004. Focus on hepatocellular carcinoma. Cancer Cell 5: 215-219.
5. Cao F, Jin TY, Zhou YF,. 2006. Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene. Biomed Environ Sci 19: 35-41.
6. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF,. 2008. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8: 187-198.
7. Chalhoub N, Baker SJ,. 2009. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 4: 127-150.
8. Chen Z, Chen GQ, Shen ZX, Sun GL, Tong JH, Wang ZY, Chen SJ,. 2002. Expanding the use of arsenic trioxide: Leukemias and beyond. Semin Hematol 39: 22-26.
9. De Smedt V, Poulhe R, Cayla X, Dessauge F, Karaiskou A, Jessus C, Ozon R,. 2002. Thr-161 phosphorylation of monomeric cdc2. Regulation by protein phosphatase 2C in Xenopus oocytes. J Biol Chem 277: 28592-28600.
10. Desai D, Wessling HC, Fisher RP, Morgan DO,. 1995. Effects of phosphorylation by CAK on cyclin binding by cdc2 and cdk2. Mol Cell Biol 15: 345-350.
11. Dilda PJ, Hogg PJ,. 2007. Arsenical-based cancer drugs. Cancer Treat Rev 33: 542-564.
12. El-Serag HB, Siegel AB, Davila JA, Shaib YH, Cayton-Woody M, McBride R, McGlynn KA,. 2006. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: A population-based study. J Hepatol 44: 158-166.
13. Fei M, Lu M, Wang Y, Zhao Y, He S, Gao S, Ke Q, Liu Y, Li P, Cui X, Shen A, Cheng C,. 2009. Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization. Med Oncol 26: 178-185.
14. Gautier J, Solomon MJ, Booher RN, Bazan JF, Kirschner MW,. 1991. cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 67: 197-211.
15. Han YH, Kim SH, Kim SZ, Park WH,. 2008a. Apoptosis in arsenic trioxide-treated Calu-6 lung cells is correlated with the depletion of GSH levels rather than the changes of ROS levels. J Cell Biochem 104: 862-878.
16. Han YH, Kim SZ, Kim SH, Park WH,. 2008b. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH. Cancer Lett 270: 40-55.
17. Hang Y, Zheng YC, Cao Y, Li QS, Sui YJ,. 2005. Suppression of gastric cancer growth by adenovirus-mediated transfer of the PTEN gene. World J Gastroenterol 11: 2224-2229.
18. Huang SM, Yang JS, Tsai SC, Chen MH, Hsu MH, Lin HY, Chou LC, Chinag JH, Lee KH, Huang LJ, Kuo SC,. 2011. The novel synthesized 2-(3-(methylamino)phenyl) -6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3) compound induces G2/M phase arrest and mitochondrial-dependent apoptotic cell death through inhibition of CDK1 and AKT activity in HL-60 human leukemia cells. Int J Oncol 38: 1357-1364.
19. Kandasamy K, Srivastava RK,. 2002. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells. Cancer Res 62: 4929-4937.
20. Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A, Hay N,. 2002. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol 22: 7831-7841.
21. Katayama K, Fujita N, Tsuruo T,. 2005. Akt/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2/M transition. Mol Cell Biol 25: 5725-5737.
22. Li Y, Qu X, Qu J, Zhang Y, Liu J, Teng Y, Hu X, Hou K, Liu Y,. 2009. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation. Cancer Lett 284: 208-215.
23. Liu B, Pan S, Dong X, Qiao H, Jiang H, Krissansen GW, Sun X,. 2006. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Cancer Sci 97: 675-681.
24. Liu ZM, Tseng JT, Hong DY, Huang HS,. 2011. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells. Biochem J 438: 349-358.
25. Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A,. 2001. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res 61: 5432-5440.
26. McGowan CH, Russell P,. 1993. Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J 12: 75-85.
27. Nigg EA,. 2001. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2: 21-32.
28. Norbury C, Blow J, Nurse P,. 1991. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J 10: 3321-3329.
29. Okumura E, Fukuhara T, Yoshida H, Hanada Si S, Kozutsumi R, Mori M, Tachibana K, Kishimoto T,. 2002. Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat Cell Biol 4: 111-116.
30. Park WH, Seol JG, Kim ES, Hyun JM, Jung CW, Lee CC, Kim BK, Lee YY,. 2000. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res 60: 3065-3071.
31. Peyrou M, Bourgoin L, Foti M,. 2010. PTEN in liver diseases and cancer. World J Gastroenterol 16: 4627-4633.
32. Redondo-Munoz J, Escobar-Diaz E, Hernandez Del Cerro M, Pandiella A, Terol MJ, Garcia-Marco JA, Garcia-Pardo A,. 2010. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation. Clin Cancer Res 16: 4382-4391.
33. Sawai H, Yasuda A, Ochi N, Ma J, Matsuo Y, Wakasugi T, Takahashi H, Funahashi H, Sato M, Takeyama H,. 2008. Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterol 8: 56.
34. Selvendiran K, Tong L, Vishwanath S, Bratasz A, Trigg NJ, Kutala VK, Hideg K, Kuppusamy P,. 2007. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. J Biol Chem 282: 28609-28618.
35. van Duijn PW, Ziel-van der Made AC, van der Korput JA, Trapman J,. 2010. PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators. Prostate 70: 135-146.
36. Wang Y, An R, Dong X, Pan S, Duan G, Sun X,. 2009. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells. Urol Int 82: 214-221.
37. Wang ZY, Chen Z,. 2008. Acute promyelocytic leukemia: From highly fatal to highly curable. Blood 111: 2505-2515.
38. Weir NM, Selvendiran K, Kutala VK, Tong L, Vishwanath S, Rajaram M, Tridandapani S, Anant S, Kuppusamy P,. 2007. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther 6: 178-184.
39. Wells NJ, Watanabe N, Tokusumi T, Jiang W, Verdecia MA, Hunter T,. 1999. The C-terminal domain of the cdc2 inhibitory kinase Myt1 interacts with cdc2 complexes and is required for inhibition of G(2)/M progression. J Cell Sci 112 (Pt 19): 3361-3371.
40. Weng JR, Bai LY, Chiu CF, Wang YC, Tsai MH,. 2012. The dietary phytochemical 3,3'-diindolylmethane induces G2/M arrest and apoptosis in oral squamous cell carcinoma by modulating Akt-NF-kappaB, MAPK, and p53 signaling. Chem Biol Interact 195: 224-230.
41. Xiong X, Ren HZ, Li MH, Mei JH, Wen JF, Zheng CL,. 2011. Down-regulated miRNA-214 induces a cell cycle G1 arrest in gastric cancer cells by up-regulating the PTEN protein. Pathol Oncol Res 17: 931-937.
42. Zhang Y, Chen LH, Wang L, Wang HM, Zhang YW, Shi YS,. 2010. Radiation-inducible PTEN expression radiosensitises hepatocellular carcinoma cells. Int J Radiat Biol 86: 964-974.
43. Zheng Y, Zhou M, Ye A, Li Q, Bai Y, Zhang Q,. 2010. The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC7901 human gastric cancer cells. World J Surg Oncol 8: 31.